Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Ifpx
AddedFeb 17, 2024
UpdatedJun 18, 2026
Ifpx

Ifpx

IFPx, an Irvine-based manufacturer, innovates patient monitoring devices for effective chronic illness management.

HQ
Irvine, CA, US
Overview
Compare
Fundraising
Employees
Website

IFPx, founded in Irvine, California, focuses on revolutionizing chronic illness management through innovative patient monitoring devices. Their core mission is to improve patient outcomes and reduce healthcare costs by directly measuring fluid buildup, starting with heart failure. This technology aims to transform how chronic conditions are managed, providing real-time data to healthcare providers for more effective treatment plans.

Notable affiliated individuals and investors have not been publicly disclosed. However, IFPx has achieved significant milestones by developing the first and only patient monitoring system that measures fluid buildup directly. This breakthrough has the potential to significantly impact the healthcare industry by addressing a critical need in managing heart failure, which is projected to drive $70 billion in healthcare costs by 2030.

Ifpx - Similar Companies

Vixiar Medical logo

Vixiar Medical

vixiar.com

Impedance Cardiology Systems logo

Impedance Cardiology Systems

CardioPhi logo

CardioPhi

Promedix logo

Promedix

promedixinc.com

iRhythm logo

iRhythm

irhythmtech.com

Respirix logo

Respirix

ivWatch logo

ivWatch

ivwatch.com

Masimo logo

Masimo

masimo.com

Flowonix Medical logo

Flowonix Medical

flowonix.com

ReThink Medical logo

ReThink Medical

Cardiac Motion logo

Cardiac Motion

Fluidnet logo

Fluidnet

Fluonic logo

Fluonic

MiraHeart logo

MiraHeart

Hifinite logo

Hifinite

hifinite.com

Ifpx - Quick Facts

Who are Ifpx's competitors?

Companies similar to Ifpx include Vixiar Medical, Impedance Cardiology Systems, CardioPhi and Promedix.

Where is Ifpx's headquarters located?

Ifpx's headquarters is located in Irvine, CA, US.

When was Ifpx's last funding round?

Ifpx's most recent funding round was for $25k (USD) in September 2023.

How much has Ifpx raised to-date?

As of Sep 28, 2023, Ifpx has raised a total of $25k (USD).

How many employees does Ifpx have?

Ifpx has 5 employees as of Feb 4, 2024.

Ifpx - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • AI
Geographic Exposure
  • United States
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified